Quyyumi, A A <br/><br/>
Long-term beneficial effects of endralazine, a new arteriolar vasodilator at rest and during exercise capacity in chronic congestive heart failure.  [electronic resource] 

 -  The American journal of cardiology  Nov 1984 
 - 1020-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9149(84)80137-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Pressure--drug effects<br/>Exercise Test<br/>Female<br/>Heart Failure--drug therapy<br/>Heart Rate--drug effects<br/>Hemodynamics--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Pulmonary Wedge Pressure--drug effects<br/>Pyridazines--therapeutic use<br/>Stroke Volume--drug effects<br/>Time Factors<br/>Vasodilator Agents--therapeutic use